Use of antibacterial agents in renal failure

Infectious Disease Clinics of North America

Volumn 15, Issue 3, 2001, Pages 983-1002

  Livornese Jr , Lawrence L ^a,c   Slavin, Dorothy ^b,c   Benz, Robert L ^b,d   Ingerman, Mark J ^b,c   Santoro, Jerome ^b,e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Division of Infectious Diseases   (United States)

^d Division of Nephrology

^e LANKENAU HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFAMANDOLE; CEFAPIRIN; CEFAZOLIN; CEFDINIR; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFPROZIL; CEFRADINE; CEFTAZIDIME; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CLARITHROMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; NETILMICIN; STREPTOMYCIN; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; CREATININE CLEARANCE; DOSE CALCULATION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PERITONEAL DIALYSIS; REVIEW;

EID: 0034850185     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70180-X     Document Type: Article

References (38)

1. Penicillin-induced coagulation disorder
2. Principles of administering drugs to patients with renal failure
3. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin
4. Recommendations for preventing the spread of vancomycin resistance
5. Prediction of creatinine clearance from serum creatinine
6. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K1 levels
7. Cefazolin in chronic hemodialysis patients: A safe, effective alternative to vancomycin
8. Trimethoprim-sulfamethoxazole-related hypoglycemia in a patient with renal failure
9. Dialyzability of common therapeutic agents
10. Use of antimicrobial agents in renal failure
11. Drug usage in dialysis patients
12. Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations
13. Drug removal during continuous renal replacement therapy
14. Drugs and peritoneal dialysis
15. Effect of dialysate temperature and flow rate of peritoneal clearance
16. False elevations of serum creatinine
17. Antacid therapy in drug kinetics
18. Toxic effects of amantadine in patients with renal failure
19. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis
20. Correlation of peritoneal transport rates with molecular weight: A method for predicting clearances
21. Adverse reactions to trimethoprim-sulfamethoxazole
22. Pharmacokinetics in patients with renal failure
23. Principles of dialysis and dialysis of drugs
24. Adverse antibiotic effects associated with renal insufficiency
25. Carbenicillin-induced bleeding disorder
26. Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimum inhibitory concentration
27. Determinants of low clearances of small solutes during peritoneal dialysis
28. Central nervous system manifestations of penicillin toxicity in man
29. The biotransformation of drugs in renal failure
30. Effect of trimethoprim on serum creatinine in patients with acute cystitis
31. Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of heparin and insulin
32. Drug interferences with clinical laboratory tests
33. Cefoxitin-induced pseudo acute renal failure
34. Solute transport in continuous hemodialysis: A new treatment for acute renal failure
35. Ticarcillin-induced hemorrhage in a patient with thrombocytosis
36. Drug clearance by continuous hemodialfiltration (CAVHD). Analysis of sieving coefficients of diffusions